Western Drugmakers Are Still Providing Medicines to Russia
Health-product companies are scaling back operations in the country, but say they have a responsibility to provide their goods
Health-product companies are scaling back operations in the country, but say they have a responsibility to provide their goods
This past October, in Baltimore, high school students had to show proof that they were fully vaccinated against COVID-19 or submit to weekly testing, in order to play sports. While Baltimore has made that call, the story is different in other neighboring districts, like Cecil County and Allegany County, where public schools are not asking for vaccination status or doing surveillance testing of any kind. Like many states across the U.S. there are no longer unified COVID protocols. Decisions on vaccine and mask mandates, events, field trips, and even if parents are allowed in school buildings are left to the individual school districts to decide.
The CDC has given the OK to lift indoor mask mandates in much of the US, and a growing number of states no longer require face coverings in schools. But most experts agree that masks slow school spread of SARS-CoV-2, and whether now is the right time to allow teachers and students to unmask is a matter of debate.
After securing contracts with the U.S. government, the Tianjin-based company's shares have surged 900 percent on the Shenzhen Stock Exchange.
A scourge that once infected millions of the world’s poorest people is close to being wiped out in humans — but infections in animals complicates the picture.
In 2020, healthcare distributors delivered over 51 billion personal protective equipment (PPE) supplies to providers on the frontlines of the fight against COVID-19.
Over 30 million adults have opted to take a pass on the COVID-19 vaccines, including around 3 million people over 65 years-old. They are exercising their personal choice to remain unprotected against the virus through vaccination, choosing to accept the associated risks.
Pfizer/BioNTech and Moderna have both begun clinical trials with an omicron-specific vaccine. Sounds good in theory, given that the majority of infections in the United States are with the omicron variant. However, there are numerous reason why such a product will not provide any additional benefits beyond the vaccines that are already available.
A data analysis conducted by the Centers for Disease Control and Prevention found the Covid-19 pandemic is linked to a rise in deaths from all causes.
Some of the 33 million adults in the nation who remain unvaccinated against COVID-19 may believe that the vaccines are risky. Medical systems around the country have debunked myths about their risk.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578